Skip to main content
Clinical Trials/NCT00764101
NCT00764101
Completed
Phase 2

Effects of Attentional Bias Modification on Attentional Bias and Symptoms of Posttraumatic Stress Disorder

PsyQ1 site in 1 country80 target enrollmentSeptember 2008

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Posttraumatic Stress Disorder
Sponsor
PsyQ
Enrollment
80
Locations
1
Primary Endpoint
Clinician-Administered PTSD Scale (CAPS)
Status
Completed
Last Updated
14 years ago

Overview

Brief Summary

Randomized, placebo-controlled trial of 9 sessions of computerized attentional bias training on attentional bias and on symptoms of Posttraumatic Stress Disorder.

Registry
clinicaltrials.gov
Start Date
September 2008
End Date
April 2010
Last Updated
14 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
PsyQ

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of Posttraumatic Stress Disorder

Exclusion Criteria

  • Diagnosis of psychosis, drug- or alcohol dependency/abuse;
  • Unable to fill in questionnaires in Dutch;
  • Color blindness (Stroop test).

Outcomes

Primary Outcomes

Clinician-Administered PTSD Scale (CAPS)

Time Frame: End of Trial + 3 week Follow-Up

Secondary Outcomes

  • PTSD symptoms (self-report)(end of trial + 3wk Follow Up)
  • Attentional Bias (dot-probe test)(End of trial + 3wk Follow-up)
  • Emotional Stroop Interference(End of trial + 3wk Follow Up)

Study Sites (1)

Loading locations...

Similar Trials